Cargando…

Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study

BACKGROUND: Pediatric multiple sclerosis (MS) is a rare disorder with significant consequences. Quantitative MRI measurements may provide significant insights, however multicenter collaborative studies are needed given the small numbers of subjects. The goal of this study is to demonstrate feasibili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chitnis, Tanuja, Guttmann, Charles R, Zaitsev, Alexander, Musallam, Alexander, Weinstock-Guttmann, Bianca, Yeh, Ann, Rodriguez, Moses, Ness, Jayne, Gorman, Mark P, Healy, Brian C, Kuntz, Nancy, Chabas, Dorothee, Strober, Jonathan B, Waubant, Emmanuelle, Krupp, Lauren, Pelletier, Daniel, Erickson, Bradley, Bergsland, Niels, Zivadinov, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832402/ https://www.ncbi.nlm.nih.gov/pubmed/24225378 http://dx.doi.org/10.1186/1471-2377-13-173

Ejemplares similares

Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity
por: Mandel, Leslie A, et al.
Publicado: (2021)

Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report
por: Chitnis, Tanuja, et al.
Publicado: (2016)

No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50
por: Bove, Riley, et al.
Publicado: (2013)

Distinct effects of obesity and puberty on risk and age at onset of pediatric MS
por: Chitnis, Tanuja, et al.
Publicado: (2016)

Assessment of Definitions of Sustained Disease Progression in Relapsing-Remitting Multiple Sclerosis
por: Healy, Brian C., et al.
Publicado: (2013)

Preventing Multiple Sclerosis: The Pediatric Perspective
por: Hardy, Duriel, et al.
Publicado: (2022)

DeepGRAI (Deep Gray Rating via Artificial Intelligence): Fast, feasible, and clinically relevant thalamic atrophy measurement on clinical quality T2-FLAIR MRI in multiple sclerosis
por: Dwyer, Michael, et al.
Publicado: (2021)

Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS
por: Deiva, Kumaran, et al.
Publicado: (2020)

Urban air quality and associations with pediatric multiple sclerosis
por: Lavery, Amy M., et al.
Publicado: (2018)

Gut microbiome is associated with multiple sclerosis activity in children
por: Horton, Mary K., et al.
Publicado: (2021)

Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG
por: Waubant, Emmanuelle, et al.
Publicado: (2019)

miRNA contributions to pediatric‐onset multiple sclerosis inferred from GWAS
por: Rhead, Brooke, et al.
Publicado: (2019)

Exploration of machine learning techniques in predicting multiple sclerosis disease course
por: Zhao, Yijun, et al.
Publicado: (2017)

Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study
por: Krupp, Lauren, et al.
Publicado: (2022)

Heterogeneity in association of remote herpesvirus infections and pediatric MS
por: Nourbakhsh, Bardia, et al.
Publicado: (2018)

Retinal Blood Vessel Analysis Using Optical Coherence Tomography (OCT) in Multiple Sclerosis
por: Young, Nicholas, et al.
Publicado: (2023)

History of fatigue in multiple sclerosis is associated with grey matter atrophy
por: Palotai, Miklos, et al.
Publicado: (2019)

Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models
por: Chua, Alicia S., et al.
Publicado: (2015)

Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry
por: Chi, Calvin, et al.
Publicado: (2019)

Decreasing brain iron in multiple sclerosis: The difference between concentration and content in iron MRI
por: Schweser, Ferdinand, et al.
Publicado: (2020)

Several household chemical exposures are associated with pediatric‐onset multiple sclerosis
por: Mar, Soe, et al.
Publicado: (2018)

Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Effect of vitamin D on MS activity by disease-modifying therapy class
por: Rotstein, Dalia L., et al.
Publicado: (2015)

Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis
por: Greenberg, Benjamin M., et al.
Publicado: (2021)

Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis
por: Barro, Christian, et al.
Publicado: (2022)

Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals
por: Hagemeier, Jesper, et al.
Publicado: (2017)

Current international trends in the treatment of multiple sclerosis in children—Impact of the COVID-19 pandemic
por: Sandesjö, Fredrik, et al.
Publicado: (2021)

Temporal association of sNfL and gad‐enhancing lesions in multiple sclerosis
por: Rosso, Mattia, et al.
Publicado: (2020)

Increased leptin and A-FABP levels in relapsing and progressive forms of MS
por: Messina, Silvia, et al.
Publicado: (2013)

Characterizing Clinical and MRI Dissociation in Patients with Multiple Sclerosis
por: Healy, Brian C., et al.
Publicado: (2017)

Switching Multiple Sclerosis Patients with Breakthrough Disease to Second-Line Therapy
por: Castillo-Trivino, Tamara, et al.
Publicado: (2011)

MRI segmentation analysis in temporal lobe and idiopathic generalized epilepsy
por: Goldberg, Hila, et al.
Publicado: (2014)

Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2012)

Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study
por: Schwartz, Carolyn E., et al.
Publicado: (2016)

Evaluation of an Online Platform for Multiple Sclerosis Research: Patient Description, Validation of Severity Scale, and Exploration of BMI Effects on Disease Course
por: Bove, Riley, et al.
Publicado: (2013)

Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI
por: Fuchs, Tom A., et al.
Publicado: (2021)

Iron deposition and inflammation in multiple sclerosis. Which one comes first?
por: Zivadinov, Robert, et al.
Publicado: (2011)

Relationships Among Circulating Levels of Hemostasis Inhibitors, Chemokines, Adhesion Molecules, and MRI Characteristics in Multiple Sclerosis
por: Ziliotto, Nicole, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lcdo4oa8cphd25a7kjkc6m76so